The global synthetic biology market is expected to grow at 17% CAGR from 2020 to 2029. It is expected to reach above USD 16.80 billion by 2029 from USD 9.55 billion in 2020. List of the Top Key ...
The renowned manufacturer and global supplier of clinical diagnostics and life science research products has a market capitalization of $9.57 billion. Bio-Rad’s earnings surpassed estimates in each of ...
Eurofins Viracor, LLC a leading provider of specialty diagnostic testing, and part of the global network of Eurofins companies, is pleased to announce the launch of an innovative quantitative PCR ...
After unlocking the secrets of DNA, the Nobel prize-winning biochemist traded in his centrifuge for a life of wine, women, and surf. [From Esquire, 1994.] ...
Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced the closing of a Series C funding round raising $105 ...